Բեռնվում է…
Comparison of Different Methods for Defining Hyperprogressive Disease in NSCLC
INTRODUCTION: Hyperprogressive disease (HPD) as a consequence of immune checkpoint inhibitors in NSCLC has been reported in multiple studies. However, inconsistent results in incidence and survival outcomes within studies, together with different assessment methods, have led to increasing controvers...
Հիմնական հեղինակներ: | , , , , , , , , , , , , |
---|---|
Ձևաչափ: | Online Հոդված Տեքստ |
Լեզու: | English |
Հրապարակվել է: |
Elsevier
2020
|
Խորագրեր: | |
Առցանց հասանելիություն: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474364/ https://www.ncbi.nlm.nih.gov/pubmed/34589976 http://dx.doi.org/10.1016/j.jtocrr.2020.100115 |